Company

About

3Z Pharmaceuticals

3Z Pharmaceuticals

Reykjavík, Iceland

3Z uses advanced disease modeling and behavioral genetics to discover novel drug candidates for CNS disorders.

Arctic Therapeutics

Arctic Therapeutics

Reykjavik, Iceland

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development, as well as sharply reducing the enormous cost and time to bring effective treatments to millions of patients. AT leverages over 20 years of international genomics research, pioneering a novel approach to guide its drug development. The company collaborates closely with The Center for Applied Genomics (CAG) at the Children’s Hospital of Philadelphia to repurpose and develop ground-breaking new medical treatments. AT-001, AT's Alzheimer‘s drug candidate, has the potential to become the first cure for dementia, not only treating the disease but preventing it. AT was founded by one of the leading minds in applied genomics, Dr. Hakon Hakonarson, who launched CAG in 2006 and established it as the largest paediatric biobank and genomic database in the world.

PLAIO

PLAIO

Bjargargötu 1, Reykjavík, 102, IS

PLAIO is a revolutionary visual planning tool for the pharmaceutical industry. The PLAIO platform uses prediction and artificial intelligence to assist planners and supply managers optimise future manufacturing needs.